Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

Business support is now available for life science companies in the South East Midlands, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF).ACTIS is a £2.1 million scheme, part-funded by ERDF, to provide support for eligible...

Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK. Collectively, the team has decades of experience in the application of platelet function testing to drug...

BioCity, the pioneering life science and business collective has announced co-investment into Rinri Therapeutics. A biotechnology company developing a novel cell-based therapy to restore hearing, Rinri Therapeutics have successfully secured £1.4 million in seed funding.BioCity’s recent investment in the biotech company, marks the 28th investment...

Nottingham-based leading DMPK provider, XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from overseas.Founded in 2011, XenoGesis now has clients across six continents and has experienced consistent growth since day one, with export revenue...

Dr Rachel Hemsley, Global Head of Business Development at Nottingham-based leading DMPK provider XenoGesis, has been appointed to the Advisory Board of BioPartner, the trade organisation for internationalising life sciences companies.BioPartner works closely with UK bioscience sector stakeholders including regional networks, national trade associations, and...